Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arcoxia for Ramadan headache prevention
NCT01148303Phase 4Completed
- Sponsor
- Hartford Hospital
- Start
- Jul 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of etoricoxib in Headache, sponsored by Hartford Hospital. Primary endpoint: Headache at 2 weeks. Started Jul 2010; status: completed.
02
Drugs
etoricoxib
03
Conditions
Headache
Beyond the preview
Go deeper on NCT01148303.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01148303.